Dr. Seneviratne is a graduate of The University of Southern California School of Medicine, and The USC Residency and Fellowship programs in Internal Medicine, Medical Oncology and Hematology. Dr. Seneviratne was a Research Fellow in Molecular Biology and Genetic Engineering at the University of San Francisco Medical Center. Dr. Seneviratne served the Los Angeles Medical Community teaching at The University of Southern California. In 2003, Dr. Seneviratne entered private practice and joined the Los Angeles Hematology/Oncology Medical Group. Dr. Seneviratne is widely published in numerous peer journals in the field of Hematology and Oncology, including The American Society of Clinical Oncology, Journal of Acquired Immune Deficiency Syndrome and Journal of the American Society of Hematology.


Dr. Lasika Seneviratne, MD
0
The iMedixStars rating goes beyond a simple average of reviews. It’s calculated based on various factors, including the quantity, recency, and reliability of the reviews. Read More
Overwiew
Doctor Organizations
- St Vincent Medical Center
Doctor Education
Medical School
1992
University Of Colombo Faculty Of Medicine
Work Place
Los Angeles Cancer Network
1245 Wilshire Blvd Ste 303
Los Angeles
CA
90017
USA
+13237609757
Specialties
Procedures performed
- Chemotherapy
Insurance Plans
- Accepts Medicare
- Accepts Medicaid
- Blue Shield CA Bronze Full PPO 4500
- Blue Cross CA Vivity
- Blue Cross CA California Care Large Group HMO
- Molina Mrktplace CA
- Aetna Vitalidad Plus CA con Aetna
- UHC Choice Plus POS
- UHC SignatureValue Flex1
- UHC Navigate HMO
- Blue Shield CA Access Plus Savenet
- LACare
- UHC West SignatureValue HMO
- First Health PPO
- Aetna HMO Deductible Plan CA only
- Blue Shield CA Platinum Access+ HMO 25
- Health Net CA CommunityCare Network HMO
- Blue Shield CA PPO
- CIGNA LocalPlus
- Blue Cross CA Pathway X PPO
- UHC West SignatureValue Advantage HMO Value Network
- Blue Shield CA Silver 70 PPO
- Health Net CA HMO Whole Care Network
- Aetna HMO
- Health Net CA HMO SmartCare
- PHCS PPO Kaiser
- UHC SignatureValue Focus
- CIGNA PPO
- Blue Cross CA Advantage PPO Preferred DirectAccess Plus
- Health Net PureCare HSP Individual and Family Plans
- Blue Cross CA Priority Select HMO
- Blue Shield CA Platinum Local Access + HMO 25
- UHC Options PPO
- CIGNA Open Access Plus
- Aetna Managed Choice POS Open Access
- Aetna Signature Administrators PPO
- PHCS PPO
- Blue Shield CA Bronze 60 PPO SHOP
- Health Net PureCare One EPO Individual & Family Plan
- Blue Shield CA 2017 I&F HMO - CoveredCA
- Blue Shield CA Trio ACO HMO
- BS CA Platinum 90 PPO
- BCBS Blue Card PPO
- Health Net CA PPO
- Blue Shield CA Access Plus HMO
- Aetna Savings Plus of CA
- Blue Cross CA Select HMO
- Blue Shield CA Local Access Plus HMO
- Multiplan PPO
- Blue Cross CA Pathway X HMO
- Blue Cross CA PPO Prudent Buyer Individual
- Health Net CA HMO Employer Group
- CIGNA HMO
- Blue Cross CA Select Plus HMO
- UHC Navigate POS
- Health Net CA Individual and Family PPO
- Anthem BC Pathway X EPO Network
- Blue Cross CA PPO Prudent Buyer Small Group
- Aetna Choice POS II
- BC CA California Care Small Group HMO
- Aetna Basic HMO
- Blue Cross CA PPO Prudent Buyer Large Group
- Oscar Insurance CA
- CIGNA Southern CA Value
- Cigna Southern CA Select
- Aexcel PPO
- Anthem Advantage HMO
- AWH Southern CA HMO
- Blue Shield CA Tandem PPO
- Classic
- Health Net CA HMO
- Health Net CA HMO Excelcare
- Health Net CA HMO Wholecare
- Health Net CA Salud HMO Plus y Mas
- Health Net EnhancedCare PPO Small Group
- Health Net SmartCare Network HMO Large Group
- Health Net SmartCare Network HMO Small Group
- MEDICA CHOICE WITH UNITEDHEALTHC
- UHC NAVIGATE PLUS POS
- UHC Nexus Open Access
- UHC Signature Value Focus
- UHC SV Flex Tier 3
Conditions
- Hodgkin's Lymphoma
- Multiple Myeloma
- Sickle-Cell Disease
- Hemolytic Anemia
- Anemia
- Vitamin B12 Deficiency Anemia
- Breast Neoplasm
- Malignant
- Iron Deficiency Anemia
- Leukemia
- Malignant Neoplasm of Female Breast
- Non-Hodgkin's Lymphoma
- Reviews
- Q&A
0 total
- 5 0 %
- 4 0 %
- 3 0 %
- 2 0 %
- 1 0 %
There are no questions!
Leave a comment